Keywords: alexion, eculizumab, begins, pnh, ph, iii, trial

Alexion's eculizumab begins PNH Ph III trial

Article | 08 November 2004

Print This

USA-based Alexion Pharmaceuticals has initiated a pivotal Phase III trial to evaluate the potential utility of its eculizumab for the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in